| Financial Year |
March 31 2023 |
| Monetary Funds |
181,403,082.94 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
161,236,488.17 |
| Advances to Suppliers |
143,805,373.12 |
| Other Receivables |
27,057,959.75 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
33,261,291.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
56,920,000.00 |
| Other Current Assets |
16,871,103.99 |
| Total Current Assets |
620,555,299.25 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
75,873,958.13 |
| Long-term Equity Investment |
4,547,410.33 |
| Investment Properties |
9,581,244.80 |
| Fixed Assetes |
905,776,818.60 |
| Under-construction Projects |
179,518,113.51 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
259,757,197.35 |
| R&D expenses |
-- |
| Goodwill |
1,195,694.03 |
| Long-Term Deferred and Prepaid Expenses |
6,083,823.10 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
1,021,305.37 |
| Sub-Total of Non-Current Assets |
1,449,807,390.76 |
| Total Assets |
2,070,362,690.01 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
151,891,075.42 |
| Accounts Received In Advance |
14,579,132.19 |
| Employee Compensation Payable |
56,743,901.74 |
| Taxes Payable |
15,372,714.34 |
| Interest Payable |
-- |
| Dividend Payable |
64,362.00 |
| Other payables |
200,793,056.92 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
17,757,285.47 |
| Other Current Liabilities |
316,732.76 |
| Sub-Total of Current Liabilities |
465,986,587.40 |
| Long-term Loans |
497,150,576.48 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
13,749,155.67 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
641,370,757.37 |
| Total Liabilities |
1,107,357,344.77 |
| Paid-In Capital(Or Share Stock) |
316,000,000.00 |
| Capital Surplus |
373,236,650.48 |
| Surplus Reserve |
32,731,026.70 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
211,784,242.35 |
| Minority Stockholder's Interest |
16,889,706.45 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
946,115,638.79 |
| Owner's Equity（Stockholder's Equity） |
963,005,345.24 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,070,362,690.01 |
